This paper analyses the relationship between the social network dimensions, the performance of Moroccan SMEs of the textile industry and their access to external resources. As these companies face a fierce competition in recent years, their CEOs' social networks are playing a significant role in their success and survival. Through a sample of 112 SMEs and a quantitative method, our results show that the more the network is important, the more it promotes SME performance and access to information resources, that having closer tie with the bankers allows a better access to financial resources, that knowing and having links with people in high places is a privilege and contributes effectively to an organizational performance.
BackgroundDrug prices are the main obstacle for the majority of the population without a health insurance regimen. A reduction in drug prices is an important regulation tool to improve access to drugs for patients. Sometimes this reduction is not well perceived by patients, in particular when they cannot advance the cost of purchasing their medication and be reimbursed later by their health insurance company.PurposeThroughout this work, we wanted to evaluate patient satisfaction regarding reduction of drug prices by the Ministry of Health. We wanted to study factors that influence patients’ appreciation of reduction in drug prices.Material and methodsA questionnaire was given to patients admitted to our hospital and affiliated with mandatory health insurance. The goal was to find out whether these price reductions were appreciated by patients and helped to improve their financial accessibility to drugs. A univariate and multivariate analysis was used to examine the factors that influence patients’ appreciation of a reduction in prices. Statistical analysis was done with SPSS 13.0.Results200 questionnaires were distributed over a 6 month period; 130 were completed correctly. Men represented 69% and married patients comprised 56%. 41% had private health insurance and the rest(59%) had public insurance. 28% were not satisfied, 37% did not feel the impact and 20% were satisfied with the reduction in prices. 6% were very unsatisfied and 9% were very satisfied. The patients’ sex and income significantly influenced their appreciation of the reduction in drug prices (p=0.042 and p=0.049). Education level, type of health insurance (public, private) and the remaining costs beyond the insured part did not influence their appreciation of the reduction in prices (p>0.05).Conclusion71% of patients were not satisfied or had not felt the impact of the reduction in drug prices on their accessibility to drugs. The reduction in drug prices did not have the desirable effect if patients had to pay for their drugs and be reimbursed later. A system of direct payment between the insurance provider and pharmacies to cover drugs costs would be more appreciated than a simple reduction in medicine prices.References and/or acknowledgementsAcknowledgements to policyholders who responded to us.No conflict of interest
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.